CNOverview
Combined with the actual needs of clinical diagnosis and treatment, and with reference to authoritative guidelines and expert consensus, this product selects the full-length coding regions, hot spot regions, and key non-coding regions of 383 important leukemia-related genes. Meanwhile, it independently adds mutant-specific probes for special types to enhance detection capability, providing molecular biological information such as diagnostic typing, prognostic stratification, medication guidance, and dynamic monitoring for leukemia patients in clinical practice.
